Literature DB >> 27134015

Heparin-gelatin mixture improves vascular reconstruction efficiency and hepatic function in bioengineered livers.

Kamal Hany Hussein1, Kyung-Mee Park2, Kyung-Sun Kang3, Heung-Myong Woo4.   

Abstract

UNLABELLED: Whole organ decellularization is a cell removal process that creates a natural extracellular matrix for use in transplantation. A lack of an intact endothelial layer in the vascular network of decellularized organs results in blood clotting even with anti-coagulation treatment. Furthermore, shear stress caused by blood flow may affect reseeded parenchymal cells. We hypothesized that a heparin-gelatin mixture (HG) can act as an antithrombotic coating reagent and induce attachment and migration of endothelial cells (ECs) on vascular wall surfaces within decellularized livers, with subsequent parenchymal cell function enhancement. Portal vein (PV) perfusion was performed for right lateral lobe decellularization of porcine livers. We tested if HG-precoating of isolated decellularized PV could increase EC attachment and migration. Additionally, we coated PV and hepatic artery walls in decellularized liver with HG, and then repopulated it with ECs and maintained it under vascular flow in a bioreactor for 10days. Re-endothelialized scaffolds were perfused with porcine blood for thrombogenicity evaluation. We then co-cultured hepatocellular carcinoma (HepG2) cells and ECs to evaluate the effect of endothelialization on parenchymal cells. Finally, we transplanted these scaffolds heterotopically in pigs. HG improved ECs' ability to migrate and adhere to vessel discs. ECs efficiently covered the vascular compartments within decellularized scaffolds and maintained function and proliferation after HG-precoating. No thrombosis was observed after 24h blood perfusion in HG-precoated scaffolds, indicating an efficiently endothelialized vascular tree. HepG2 cells displayed a higher function in scaffolds endothelialized after HG-precoating compared to uncoated scaffolds in vitro and after in vivo transplantation. Our results lay the groundwork for engineering human-sized whole-liver scaffolds for clinical applications. STATEMENT OF SIGNIFICANCE: A major obstacle to successful organ bioengineering is vasculature reconstruction to avoid thrombosis and deliver nutrients through blood to the whole scaffold after in vivo transplantation. Although many attempts have been made to construct endothelial cell layers on the vascular network within decellularized organs, complete coverage has not be achieved. Here, we describe an effective approach for endothelial cell seeding to reconstruct a patent vascular tree within decellularized livers by coating the vasculature using heparin-gelatin mixture. Our results have demonstrate that enhancement of endothelial cell attachment by heparin-gelatin treatment could improve vascular patency and parenchymal cell function in vitro and in vivo. These results represent a significant advancement toward bioengineering functional liver tissue that maintains vascular patency for transplantation.
Copyright © 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Decellularized livers; Endothelialization; Liver tissue engineering; Transplantation; Vascular reconstruction

Mesh:

Substances:

Year:  2016        PMID: 27134015     DOI: 10.1016/j.actbio.2016.04.042

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  20 in total

1.  Wnt ligands 3a and 5a regulate proliferation and migration in human fetal liver progenitor cells.

Authors:  Zhiwen Liu; Vijay Kumar Kuna; Bo Xu; Suchitra Sumitran-Holgersson
Journal:  Transl Gastroenterol Hepatol       Date:  2021-10-25

2.  Constructing a heparin-modified penile decellularized scaffold to improve re-endothelialization in organizational reconstruction.

Authors:  Houliang Zhang; Xinran Song; Jinliang Ni; Weipu Mao; Changxiu Tian; Jinbo Xie; Yifan Zhang; Yidi Wang; Jian Wan; Keyi Wang; Bo Peng
Journal:  Transl Androl Urol       Date:  2022-05

Review 3.  Emerging advancements in liver regeneration and organogenesis as tools for liver replacement.

Authors:  Stacey S Huppert; Kathleen M Campbell
Journal:  Curr Opin Organ Transplant       Date:  2016-12       Impact factor: 2.640

4.  Improving functional re-endothelialization of acellular liver scaffold using REDV cell-binding domain.

Authors:  Julie Devalliere; Yibin Chen; Kevin Dooley; Martin L Yarmush; Basak E Uygun
Journal:  Acta Biomater       Date:  2018-07-31       Impact factor: 8.947

5.  cAMP/EPAC Signaling Enables ETV2 to Induce Endothelial Cells with High Angiogenesis Potential.

Authors:  Jae-Jun Kim; Da-Hyun Kim; Jin Young Lee; Byung-Chul Lee; Insung Kang; Myung Geun Kook; Dasom Kong; Soon Won Choi; Heung-Myong Woo; Dong-Ik Kim; Kyung-Sun Kang
Journal:  Mol Ther       Date:  2019-11-27       Impact factor: 11.454

6.  Syndecan-4 promotes vascular beds formation in tissue engineered liver via thrombospondin 1.

Authors:  Xiaoyi Hu; Junjie Chen; Hechen Huang; Shengyong Yin; Shusen Zheng; Lin Zhou
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

Review 7.  Natural Scaffolds Used for Liver Regeneration: A Narrative Update.

Authors:  Masoud Vazirzadeh; Negar Azarpira; Parsa Davoodi; Massoud Vosough; Kamran Ghaedi
Journal:  Stem Cell Rev Rep       Date:  2022-03-23       Impact factor: 6.692

Review 8.  Liver tissue engineering: From implantable tissue to whole organ engineering.

Authors:  Giuseppe Mazza; Walid Al-Akkad; Krista Rombouts; Massimo Pinzani
Journal:  Hepatol Commun       Date:  2017-12-21

9.  Multi-component hybrid hydrogels - understanding the extent of orthogonal assembly and its impact on controlled release.

Authors:  Vânia M P Vieira; Laura L Hay; David K Smith
Journal:  Chem Sci       Date:  2017-08-24       Impact factor: 9.825

Review 10.  Whole Organ Tissue Vascularization: Engineering the Tree to Develop the Fruits.

Authors:  Alessandro F Pellegata; Alfonso M Tedeschi; Paolo De Coppi
Journal:  Front Bioeng Biotechnol       Date:  2018-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.